Skip to content
XPR – Lifestyle Demo
Author:
AMERICAN DIABETES ASSOCIATION
Novel Once-Daily Pill Delivers Positive Blood Glucose and Weight Reduction Results
June 8, 2026
ACHIEVE Trials Demonstrate Comparative Benefits of Novel, Small-Molecule Oral GLP-1 RA, Expanding Oral Treatment Options for Patient Population in Need of Alternative Solutions
June 8, 2026
Once-Weekly CagriSema (Amylin-Semaglutide) Combination Injection More Effective than Standalone Medications
June 7, 2026
Lipid-Lowering Medications Demonstrate Cardiometabolic Benefits in Populations with High-Risk Diabetes
June 7, 2026
Once-Weekly Drug Demonstrates Promising Dual Benefits in Obesity and Metabolic Health
June 7, 2026
The American Diabetes Association Announces Winners of the Innovation Challenge
June 6, 2026
82% of Adults with Type 2 Diabetes Not on Insulin Improve Blood Glucose Levels with Continuous Glucose Monitoring
June 6, 2026
Breakthrough Studies Demonstrate Effectiveness of the First Triple-Hormone Therapy for Type 2 Diabetes and Obesity
June 6, 2026
Ultra-Long-Acting Injectable GLP-1 RA Shows Promise for Supporting Weight Management in Individuals With and Without Type 2 Diabetes
June 6, 2026
Machine Learning Model Accurately Predicts Long-Term Risk of Type 2 Diabetes
June 5, 2026
1
2
Next Page
→